Skip to main content
. 2025 May 17;24:181. doi: 10.1186/s12944-025-02599-2

Table 2.

Association of ABSI and PEF (Multiple imputation)

Categories Model 1 Model 2 Model 3 Model 4
β(95%CI) P value β(95%CI) P value β(95%CI) P value β(95%CI) P value
All ABSI** 15.38 (12.13 ~ 18.63)  < 0.001 −6.28 (−9.56 ~ −3.00)  < 0.001 −6.22 (−9.87 ~ −2.57) 0.001 −6.15 (−10.13 ~ −2.17) 0.002
ABSI** Quintile
Q1 (1.70 ~ 6.86) 0(Ref) 0(Ref) 0(Ref) 0(Ref) 0(Ref) 0(Ref) 0(Ref) 0(Ref)
Q2 (6.86 ~ 7.18) 5.11 (−1.22 ~ 11.44) 0.114 3.48 (−1.98 ~ 8.94) 0.211 3.09 (−2.95 ~ 9.12) 0.317 3.81 (−2.71 ~ 10.33) 0.252
Q3 (7.18 ~ 7.46) 30.50 (24.17 ~ 36.83)  < 0.001 3.20 (−2.57 ~ 8.96) 0.277 3.76 (−2.60 ~ 10.12) 0.246 3.67 (−3.22 ~ 10.57) 0.296
Q4 (7.46 ~ 7.76) 54.48 (48.15 ~ 60.81)  < 0.001 3.81 (−2.40 ~ 10.03) 0.229 3.90 (−2.94 ~ 10.75) 0.264 0.97 (−6.53 ~ 8.47) 0.799
Q5 (7.76 ~ 11.40) 28.22 (21.89 ~ 34.55)  < 0.001 −13.19 (−19.83 ~ −6.55)  < 0.001 −13.36 (−20.68 ~ −6.03)  < 0.001 −13.81 (−21.91 ~ −5.71) 0.001
P for trend  < 0.001 0.001 0.003 0.003
Male
ABSI** −35.17 (−41.35 ~ −28.99)  < 0.001 −10.62 (−16.6 ~ −4.64) 0.001 −10.03 (−16.73 ~ −3.33) 0.003 −9.83 (−17.26 ~ −2.40) 0.010
ABSI** Quintile
Q1 (2.31 ~ 7.29) 0(Ref) 0(Ref) 0(Ref) 0(Ref) 0(Ref) 0(Ref) 0(Ref) 0(Ref)
Q2 (7.29 ~ 7.51) 8.58 (−1.34 ~ 18.50) 0.090 7.39 (−1.93 ~ 16.71) 0.120 6.87 (−3.68 ~ 17.42) 0.202 5.43 (−5.96 ~ 16.83) 0.350
Q3 (7.51 ~ 7.71) −0.52 (−10.44 ~ 9.40) 0.919 5.87 (−3.44 ~ 15.18) 0.216 4.71 (−5.81 ~ 15.24) 0.380 −0.21 (−11.76 ~ 11.34) 0.972
Q4 (7.71 ~ 7.93) −11.56 (−21.48 ~ −1.64) 0.022 4.64 (−4.76 ~ 14.04) 0.334 1.30 (−9.34 ~ 11.95) 0.810 −1.45 (−13.17 ~ 10.27) 0.809
Q5 (7.93 ~ 11.40) −52.89 (−62.81 ~ −42.97)  < 0.001 −12.84 (−22.51 ~ −3.17) 0.009 −10.71 (−21.45 ~ 0.03) 0.051 −13.32 (−25.32 ~ −1.31) 0.030
P for trend  < 0.001 0.017 0.032 0.018
Female
ABSI** −28.89 (−32.18 ~ −25.60)  < 0.001 −7.19 (−10.59 ~ −3.78)  < 0.001 −6.98 (−10.76 ~ −3.19)  < 0.001 −6.80 (−10.89 ~ −2.71) 0.001
ABSI** Quintile
Q1 (1.70 ~ 6.67) 0(Ref) 0(Ref) 0(Ref) 0(Ref) 0(Ref) 0(Ref) 0(Ref) 0(Ref)
Q2 (6.67 ~ 6.92) 2.77 (−3.11 ~ 8.66) 0.356 2.77 (−3.11 ~ 8.66) 0.356 1.76 (−4.8 ~ 8.33) 0.598 0.60 (−6.44 ~ 7.65) 0.867
Q3 (6.92 ~ 7.13) −0.61 (−6.51 ~ 5.29) 0.840 −0.61 (−6.51 ~ 5.29) 0.840 0.36 (−6.18 ~ 6.89) 0.914 1.09 (−5.97 ~ 8.15) 0.762
Q4 (7.13 ~ 7.40) −5.53 (−11.56 ~ 0.50) 0.072 −5.53 (−11.56 ~ 0.50) 0.072 −2.90 (−9.53 ~ 3.72) 0.390 −3.44 (−10.64 ~ 3.76) 0.349
Q5 (7.40 ~ 10.00) −16.48 (−22.89 ~ −10.07)  < 0.001 −16.48 (−22.89 ~ −10.07)  < 0.001 −13.75 (−20.75 ~ −6.75)  < 0.001 −13.99 (−21.64 ~ −6.35)  < 0.001
P for trend  < 0.001  < 0.001  < 0.001  < 0.001

ABSI a body shape index, PEF peak expiratory flow, TC total cholesterol, TG triglycerides, LDL low-density lipoprotein, β coefficient, CI confidence interval

Model 1: not adjusted

Model 2: adjusted for age, race, residence, educational status, marital status, sleep duration(total population adjusted for sex)

Model 3: adjusted for model 2, additionally adjusted for smoking status, drinking status, hypertension, diabetes, heart diseases, stroke, dyslipidemias, kidney diseases

Model 4: adjusted for model 3, additionally adjusted for creatinine, glucose, TC, TG, LDL, Cystatin C

**Continuous variable: ABSI was scaled by a factor of 100